BioScience Health Innovations (BHIC) Receivables - Net (2023 - 2025)
BioScience Health Innovations (BHIC) has disclosed Receivables - Net for 3 consecutive years, with $399257.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 298.12% to $399257.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $399257.0 through Dec 2025, up 298.12% year-over-year, with the annual reading at $399257.0 for FY2025, 298.12% up from the prior year.
- Receivables - Net for Q4 2025 was $399257.0 at BioScience Health Innovations, up from $63212.0 in the prior quarter.
- The five-year high for Receivables - Net was $399257.0 in Q4 2025, with the low at $3849.0 in Q1 2023.
- Average Receivables - Net over 3 years is $100168.7, with a median of $34180.5 recorded in 2023.
- The sharpest move saw Receivables - Net surged 70.51% in 2024, then soared 1311.56% in 2025.
- Over 3 years, Receivables - Net stood at $36448.0 in 2023, then surged by 175.15% to $100285.0 in 2024, then skyrocketed by 298.12% to $399257.0 in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $399257.0, $63212.0, and $390013.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.